A good year just got even better in strategic terms for cardiac surgery and neuroscience group LivaNova PLC. In September, the reborn and reshaped combination of Cyberonics and Sorin signaled that its $249 million CRM business was no longer a strategic fit.
In bringing a new broom effect to the London-based group, CEO Damien McDonald has maximized talent, and optimized market coverage and innovation potential with new purchases. But CRM would be...
Nevertheless, the reasons were right, as he and senior colleagues explained at the group's investor road show in September. LivaNova's CRM business is strong regionally, with "valuable assets, innovative technologies,...